Position in LGND
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$7,708,885
-$561,414 QoQ
Shares Held
38,612
-11.7% QoQ
Ownership
0.193%
of shares outstanding
% of Portfolio
1.95%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Lisanti Capital Growth, LLC holds $47,213,606 across 13 Biotechnology names. LGND ranks #1 (16.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
This page
|
38,612 | $7,708,885 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
75,699 | $5,684,237 | |
| 3 | PVLA |
Palvella Therapeutics, Inc.
|
41,445 | $5,166,119 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
18,515 | $4,782,794 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
52,260 | $4,398,724 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
22,075 | $3,731,116 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
39,005 | $3,603,281 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
54,445 | $3,518,780 |
All Filings in LGND
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,708,885 | 38,612 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $8,270,299 | 43,742 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $5,256,983 | 29,677 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,213,534 | 10,675 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $5,527,735 | 52,575 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $4,179,921 | 39,010 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,480,730 | 24,785 | Shares | Sole | 2024-11-04 | |
| No filing history on record for this holder in this stock. | ||||||